Heidelberg Pharma AG (FRA:HPHA)
Germany
· Delayed Price · Currency is EUR 2.840
+0.010 (0.35%)
At close: Dec 4, 2025
Heidelberg Pharma AG Balance Sheet
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 22.87 | 29.42 | 43.44 | 81.33 | 6.14 | 4.98 | Upgrade
|
| Cash & Short-Term Investments | 22.87 | 29.42 | 43.44 | 81.33 | 6.14 | 4.98 | Upgrade
|
| Cash Growth | -37.46% | -32.27% | -46.59% | 1224.27% | 23.27% | -49.59% | Upgrade
|
| Accounts Receivable | 0.06 | 0.28 | 0.98 | 1.1 | 1.02 | 1.19 | Upgrade
|
| Other Receivables | 1.43 | 5.66 | 1.34 | 0.35 | 0.43 | 0.32 | Upgrade
|
| Receivables | 1.49 | 5.94 | 2.31 | 1.45 | 1.45 | 1.51 | Upgrade
|
| Inventory | 16.13 | 11.83 | 10.5 | 4.59 | 0.75 | 0.23 | Upgrade
|
| Prepaid Expenses | 0.46 | - | - | - | - | - | Upgrade
|
| Other Current Assets | -0 | 0.37 | 0.38 | 0.51 | 0.68 | 0.8 | Upgrade
|
| Total Current Assets | 40.95 | 47.57 | 56.63 | 87.88 | 9.01 | 7.52 | Upgrade
|
| Property, Plant & Equipment | 3.06 | 3.49 | 3.85 | 3.72 | 3.67 | 3.11 | Upgrade
|
| Goodwill | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | Upgrade
|
| Other Intangible Assets | 2.73 | 2.75 | 2.79 | 2.84 | 2.9 | 2.82 | Upgrade
|
| Other Long-Term Assets | 1.2 | 0.81 | 0.97 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Total Assets | 54.05 | 60.72 | 70.35 | 100.58 | 21.73 | 19.61 | Upgrade
|
| Accounts Payable | 5.65 | 5.55 | 7.88 | 5.75 | 2.96 | 2.81 | Upgrade
|
| Accrued Expenses | - | 0.94 | 1.04 | 1.03 | 0.78 | 3.46 | Upgrade
|
| Short-Term Debt | - | - | 5.65 | 15.79 | 10.47 | - | Upgrade
|
| Current Portion of Leases | 0.09 | 0.12 | 0.11 | 0.09 | 0.09 | 0.1 | Upgrade
|
| Current Unearned Revenue | 0.01 | 1.2 | 4.97 | 5.02 | 0.49 | 0.25 | Upgrade
|
| Other Current Liabilities | 1.25 | 0.19 | 0.13 | 0.25 | 0.15 | -0 | Upgrade
|
| Total Current Liabilities | 7 | 8 | 19.78 | 27.93 | 14.93 | 6.63 | Upgrade
|
| Long-Term Leases | 0.04 | 0.05 | 0.07 | 0.1 | 0.08 | 0.1 | Upgrade
|
| Long-Term Unearned Revenue | 36.48 | - | 1.17 | 5.9 | 0.02 | - | Upgrade
|
| Other Long-Term Liabilities | - | 21.81 | - | - | - | - | Upgrade
|
| Total Liabilities | 43.52 | 29.85 | 21.01 | 33.94 | 15.03 | 6.73 | Upgrade
|
| Common Stock | 46.78 | 46.6 | 46.6 | 46.58 | 34.18 | 31.06 | Upgrade
|
| Additional Paid-In Capital | 304.99 | 304.78 | 304.78 | 304.74 | 238.05 | 221.9 | Upgrade
|
| Retained Earnings | -352.18 | -331.12 | -311.74 | -291.39 | -271.69 | -245.55 | Upgrade
|
| Comprehensive Income & Other | 10.94 | 10.6 | 9.7 | 6.71 | 6.16 | 5.47 | Upgrade
|
| Shareholders' Equity | 10.53 | 30.87 | 49.34 | 66.64 | 6.7 | 12.88 | Upgrade
|
| Total Liabilities & Equity | 54.05 | 60.72 | 70.35 | 100.58 | 21.73 | 19.61 | Upgrade
|
| Total Debt | 0.13 | 0.16 | 5.83 | 15.98 | 10.63 | 0.2 | Upgrade
|
| Net Cash (Debt) | 22.74 | 29.26 | 37.61 | 65.35 | -4.49 | 4.78 | Upgrade
|
| Net Cash Growth | -37.55% | -22.20% | -42.45% | - | - | -51.64% | Upgrade
|
| Net Cash Per Share | 0.48 | 0.63 | 0.81 | 1.76 | -0.14 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 47.15 | 46.6 | 46.6 | 46.58 | 34.18 | 31.06 | Upgrade
|
| Total Common Shares Outstanding | 47.15 | 46.6 | 46.6 | 46.58 | 34.18 | 31.06 | Upgrade
|
| Working Capital | 33.95 | 39.57 | 36.86 | 59.95 | -5.92 | 0.89 | Upgrade
|
| Book Value Per Share | 0.22 | 0.66 | 1.06 | 1.43 | 0.20 | 0.41 | Upgrade
|
| Tangible Book Value | 1.69 | 22.01 | 40.44 | 57.7 | -2.31 | 3.95 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.47 | 0.87 | 1.24 | -0.07 | 0.13 | Upgrade
|
| Machinery | - | 10.7 | 10.34 | 9.5 | 8.91 | 7.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.